Angela Katz1, Barbara L. Smith1, Mehra Golshan1, Andrzej Niemierko1, Wendy Kobayashi1, Rita Abi Raad1, A. Kelada1, Levi Rizk1, Julia S. Wong1, Jennifer R. Bellon1, Michele A. Gadd1, Michelle C. Specht1, Alphonse G. Taghian1
1From the Departments of Radiation Oncology and Surgery, Massachusetts General Hospital; and the Departments of Surgery and Radiation Oncology, Brigham and Women's Hospital, Boston, MA
Tóm tắt
Purpose The standard of care for patients with a positive (+) sentinel lymph node (SLN) is axillary dissection; however, for various reasons, some SLN+ patients do not undergo dissection. The purpose of this study was to define possible predictors of having four or more involved nodes to provide information for clinicians and patients making decisions about adjuvant chemotherapy and radiation. Patients and Methods We reviewed the records of 402 patients with invasive breast cancer and one to three involved SLNs who underwent completion axillary dissection at two academic cancer centers. None of these patients received neoadjuvant chemotherapy. Factors associated with having four or more involved axillary nodes (SLNs and non-SLNs) were evaluated by univariate and multivariate logistic regression analysis. Results Eighty-seven patients had four or more positive nodes. On multivariate analysis, having four or more SLNs was associated with tumor histology, primary tumor size, lymphovascular space invasion, extranodal extension, the number of involved SLNs, the number of uninvolved SLNs, and the size of the largest SLN metastasis. A nomogram to predict the probability of having four or more nodes based on patients’ pathologic data was developed from the multivariate logistic regression model. A separate previously published data set of 206 SLN+ patients treated at a community hospital in another city was used to validate this model. Conclusion Patients with a low probability of having four or more nodes can be identified from known pathologic features. The nomogram developed will be helpful to clinicians making adjuvant treatment recommendations.
